{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:53:17Z","timestamp":1778543597893,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100021078","name":"Norwegian Institute of Public Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100021078","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Patients with metastatic testicular cancer (TC) treated with cisplatin-based chemotherapy (CBCT) are prone to develop metabolic syndrome (MetS). In an epigenome wide association study in patients with TC we have shown that DNA methylation was associated to CBCT. The aim of the study was to investigate whether there was a change in DNA methylation after treatment with CBCT, and if methylation status is related to the presence or development of MetS. In a prospective cohort of 67 TC patients who received CBCT, we assessed whole blood global methylation long interspersed nuclear element-1 (LINE-1) and DNA methylation at selected cytosine-phosphate-guanine dinucleotide (CpG) sites associated with MetS using targeted sequencing. Measured samples were taken before, one month after, and one year after CBCT. Development of MetS was assessed before and up to five years after CBCT. Serum platinum levels were measured to assess platinum exposure (PtAUC) within the first year after the start of CBCT. Data were used for paired comparisons, comparisons between groups, statistical modeling to account for covariates, and machine learning approaches to predict occurrence of MetS five years after diagnosis. Global methylation did not change during the first year after the start of CBCT (median 73.7% (25th -75th percentile 72.0\u201375.2) vs. 73.9% (72.5\u201375.1)). Seven out of the 16 other selected CpGs decreased. Patients with MetS before start of CBCT (\n                    <jats:italic>N<\/jats:italic>\n                    \u2009=\u200918) showed a larger decrease than patients without MetS (\n                    <jats:italic>N<\/jats:italic>\n                    \u2009=\u200949) for AC090023 (-11.6% vs. -8.2%,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.008), NCAM2 (-6.5% vs. -1.6%,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.030), and TOM1L2 (-5.8% vs. -2.6%,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.003). The 15 patients who did not have MetS prior to CBCT, but developed MetS within five years after treatment showed an increase in global methylation (1.5% vs. \u2212\u20090.6%,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.008) after one year, and a decrease in TOM1L2 methylation (-4.0% vs. -1.6%,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.015) when compared to patients who did not have prior to CBCT nor developed MetS (\n                    <jats:italic>N<\/jats:italic>\n                    \u2009=\u200934). There was no difference in PtAUC during the first year after the start of CBCT between the latter groups (70.0 vs. 67.9 days*mg\/L,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.206). Changes in global DNA methylation and TOM1L2 one year after the start of CBCT are associated with a higher risk for newly developing MetS within five years. This may indicate potential for tailored advice, based on epigenetic status, to patients treated with chemotherapy for TC to prevent development of MetS.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-22918-y","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:57:48Z","timestamp":1762883868000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Changes in methylation associated with development of metabolic syndrome in testicular cancer patients treated with cisplatin chemotherapy"],"prefix":"10.1038","volume":"15","author":[{"given":"Marcin W.","family":"Wojewodzic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen L.D.","family":"Volders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coby","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Grotmol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daan J.","family":"Touw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sjoukje","family":"Lubberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trine B.","family":"Haugen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jourik A.","family":"Gietema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trine B.","family":"Rounge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"issue":"3","key":"22918_CR1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.7326\/0003-4819-87-3-293","volume":"87","author":"LH Einhorn","year":"1977","unstructured":"Einhorn, L. H. & Donohue, J. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann. Intern. Med. 87 (3), 293\u2013298 (1977).","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"22918_CR2","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/ijc.33999","volume":"151","author":"A Znaor","year":"2022","unstructured":"Znaor, A. et al. Global patterns in testicular cancer incidence and mortality in 2020. Int. J. Cancer. 151 (5), 692\u2013698 (2022).","journal-title":"Int. J. Cancer"},{"issue":"4","key":"22918_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41585-021-00440-w","volume":"18","author":"M Chovanec","year":"2021","unstructured":"Chovanec, M. et al. Late adverse effects and quality of life in survivors of testicular germ cell tumour. Nat. Rev. Urol. 18 (4), 227\u2013245 (2021).","journal-title":"Nat. Rev. Urol."},{"issue":"12","key":"22918_CR4","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.annonc.2023.09.3101","volume":"34","author":"SD Fossa","year":"2023","unstructured":"Fossa, S. D. et al. Adverse health outcomes and global quality of life in long-term testicular cancer survivors: a longitudinal 30-year perspective. Ann. Oncol. 34 (12), 1165\u20131174 (2023).","journal-title":"Ann. Oncol."},{"issue":"32","key":"22918_CR5","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1200\/JCO.21.00637","volume":"39","author":"R Hellesnes","year":"2021","unstructured":"Hellesnes, R. et al. Testicular cancer in the cisplatin era: causes of death and mortality rates in a Population-Based cohort. J. Clin. Oncol. 39 (32), 3561\u20133573 (2021).","journal-title":"J. Clin. Oncol."},{"issue":"19","key":"22918_CR6","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1200\/JCO.22.01016","volume":"41","author":"S Lubberts","year":"2023","unstructured":"Lubberts, S. et al. Cardiovascular disease in testicular cancer survivors: identification of risk factors and impact on quality of life. J. Clin. Oncol. 41 (19), 3512\u20133522 (2023).","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"22918_CR7","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1002\/ijc.34625","volume":"153","author":"L Thorsen","year":"2023","unstructured":"Thorsen, L. et al. Association of physical activity with overall mortality among long-term testicular cancer survivors: A longitudinal study. Int. J. Cancer. 153 (8), 1512\u20131519 (2023).","journal-title":"Int. J. Cancer"},{"key":"22918_CR8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ejca.2016.05.022","volume":"63","author":"S Lubberts","year":"2016","unstructured":"Lubberts, S. et al. Vascular fingerprint and vascular damage markers associated with vascular events in testicular cancer patients during and after chemotherapy. Eur. J. Cancer. 63, 180\u2013188 (2016).","journal-title":"Eur. J. Cancer"},{"issue":"10","key":"22918_CR9","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1080\/15592294.2020.1834926","volume":"16","author":"Z Fazal","year":"2021","unstructured":"Fazal, Z. et al. Hypermethylation and global remodelling of DNA methylation is associated with acquired cisplatin resistance in testicular germ cell tumours. Epigenetics 16 (10), 1071\u20131084 (2021).","journal-title":"Epigenetics"},{"issue":"1","key":"22918_CR10","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1038\/s41598-023-30957-6","volume":"13","author":"F Gao","year":"2023","unstructured":"Gao, F., Xu, Q., Jiang, Y. & Lu, B. A novel DNA methylation signature to improve survival prediction of progression-free survival for testicular germ cell tumors. Sci. Rep. 13 (1), 3759 (2023).","journal-title":"Sci. Rep."},{"issue":"4","key":"22918_CR11","doi-asserted-by":"publisher","first-page":"893","DOI":"10.7150\/jca.27491","volume":"10","author":"H Bo","year":"2019","unstructured":"Bo, H. et al. A network-based approach to identify DNA methylation and its involved molecular pathways in testicular germ cell tumors. J. Cancer. 10 (4), 893\u2013902 (2019).","journal-title":"J. Cancer"},{"issue":"2","key":"22918_CR12","doi-asserted-by":"publisher","first-page":"662","DOI":"10.21037\/tau-20-963","volume":"10","author":"R Cong","year":"2021","unstructured":"Cong, R. et al. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor. Transl Androl. Urol. 10 (2), 662\u2013679 (2021).","journal-title":"Transl Androl. Urol."},{"issue":"4","key":"22918_CR13","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/1878-0261.12909","volume":"15","author":"J Lobo","year":"2021","unstructured":"Lobo, J. et al. Promoter methylation of DNA homologous recombination genes is predictive of the responsiveness to PARP inhibitor treatment in testicular germ cell tumors. Mol. Oncol. 15 (4), 846\u2013865 (2021).","journal-title":"Mol. Oncol."},{"issue":"1","key":"22918_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13148-021-01048-y","volume":"13","author":"J Lobo","year":"2021","unstructured":"Lobo, J. et al. Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples. Clin. Epigenetics. 13 (1), 70 (2021).","journal-title":"Clin. Epigenetics"},{"issue":"7","key":"22918_CR15","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.3390\/cancers13071506","volume":"13","author":"R Singh","year":"2021","unstructured":"Singh, R., Fazal, Z., Freemantle, S. J. & Spinella, M. J. Between a rock and a hard place: An Epigenetic-Centric view of testicular germ cell tumors. Cancers (Basel) 13 (7), 1506\u20131526 (2021).","journal-title":"Cancers (Basel)"},{"issue":"5","key":"22918_CR16","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1080\/07315724.2018.1553116","volume":"38","author":"LL Lopes","year":"2019","unstructured":"Lopes, L. L., Bressan, J., Peluzio, M. & Hermsdorff, H. H. M. LINE-1 in obesity and cardiometabolic diseases: A systematic review. J. Am. Coll. Nutr. 38 (5), 478\u2013484 (2019).","journal-title":"J. Am. Coll. Nutr."},{"issue":"7","key":"22918_CR17","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3109\/1354750X.2016.1171904","volume":"21","author":"JC Carraro","year":"2016","unstructured":"Carraro, J. C. et al. LINE-1 and inflammatory gene methylation levels are early biomarkers of metabolic changes: association with adiposity. Biomarkers 21 (7), 625\u2013632 (2016).","journal-title":"Biomarkers"},{"issue":"6","key":"22918_CR18","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.numecd.2013.11.011","volume":"24","author":"W Perng","year":"2014","unstructured":"Perng, W. et al. Dietary intake, plasma homocysteine, and repetitive element DNA methylation in the Multi-Ethnic study of atherosclerosis (MESA). Nutr. Metab. Cardiovasc. Dis. 24 (6), 614\u2013622 (2014).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"9","key":"22918_CR19","doi-asserted-by":"publisher","first-page":"e25254","DOI":"10.1371\/journal.pone.0025254","volume":"6","author":"KB Michels","year":"2011","unstructured":"Michels, K. B., Harris, H. R. & Barault, L. Birthweight, maternal weight trajectories and global DNA methylation of LINE-1 repetitive elements. PLoS One. 6 (9), e25254 (2011).","journal-title":"PLoS One"},{"issue":"1","key":"22918_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/15592294.2015.1135286","volume":"11","author":"JL Marques-Rocha","year":"2016","unstructured":"Marques-Rocha, J. L. et al. LINE-1 methylation is positively associated with healthier lifestyle but inversely related to body fat mass in healthy young individuals. Epigenetics 11 (1), 49\u201360 (2016).","journal-title":"Epigenetics"},{"issue":"1","key":"22918_CR21","doi-asserted-by":"publisher","first-page":"e54544","DOI":"10.1371\/journal.pone.0054544","volume":"8","author":"CJ Piyathilake","year":"2013","unstructured":"Piyathilake, C. J., Badiga, S., Alvarez, R. D., Partridge, E. E. & Johanning, G. L. A lower degree of PBMC L1 methylation is associated with excess body weight and higher HOMA-IR in the presence of lower concentrations of plasma folate. PLoS One. 8 (1), e54544 (2013).","journal-title":"PLoS One"},{"issue":"4","key":"22918_CR22","doi-asserted-by":"publisher","first-page":"e62587","DOI":"10.1371\/journal.pone.0062587","volume":"8","author":"W Perng","year":"2013","unstructured":"Perng, W. et al. A prospective study of LINE-1DNA methylation and development of adiposity in school-age children. PLoS One. 8 (4), e62587 (2013).","journal-title":"PLoS One"},{"issue":"1","key":"22918_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1868-7083-4-10","volume":"4","author":"V Turcot","year":"2012","unstructured":"Turcot, V. et al. LINE-1 methylation in visceral adipose tissue of severely obese individuals is associated with metabolic syndrome status and related phenotypes. Clin. Epigenetics. 4 (1), 10 (2012).","journal-title":"Clin. Epigenetics"},{"key":"22918_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13148-017-0327-5","volume":"9","author":"J Dunstan","year":"2017","unstructured":"Dunstan, J. et al. Associations of LEP, CRH, ICAM-1, and LINE-1 methylation, measured in saliva, with waist circumference, body mass index, and percent body fat in mid-childhood. Clin. Epigenetics. 9, 29 (2017).","journal-title":"Clin. Epigenetics"},{"issue":"3","key":"22918_CR25","first-page":"26","volume":"2","author":"AM Manzardo","year":"2016","unstructured":"Manzardo, A. M. & Butler, M. G. Examination of global methylation and targeted imprinted genes in Prader-Willi syndrome. J Clin. Epigenet 2 (3), 26\u201336 (2016).","journal-title":"J Clin. Epigenet"},{"issue":"7","key":"22918_CR26","doi-asserted-by":"publisher","first-page":"e41361","DOI":"10.1371\/journal.pone.0041361","volume":"7","author":"LE Reinius","year":"2012","unstructured":"Reinius, L. E. et al. Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS One. 7 (7), e41361 (2012).","journal-title":"PLoS One"},{"issue":"1","key":"22918_CR27","doi-asserted-by":"publisher","first-page":"5743","DOI":"10.1038\/s41598-020-62262-x","volume":"10","author":"R Sadahiro","year":"2020","unstructured":"Sadahiro, R. et al. Major surgery induces acute changes in measured DNA methylation associated with immune response pathways. Sci. Rep. 10 (1), 5743 (2020).","journal-title":"Sci. Rep."},{"issue":"1","key":"22918_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s13148-019-0764-4","volume":"11","author":"C Bucher-Johannessen","year":"2019","unstructured":"Bucher-Johannessen, C. et al. Cisplatin treatment of testicular cancer patients introduces long-term changes in the epigenome. Clin. Epigenetics. 11 (1), 179 (2019).","journal-title":"Clin. Epigenetics"},{"issue":"9","key":"22918_CR29","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/j.1600-0854.2010.01098.x","volume":"11","author":"T Wang","year":"2010","unstructured":"Wang, T., Liu, N. S., Seet, L. F. & Hong, W. The emerging role of VHS domain-containing Tom1, Tom1L1 and Tom1L2 in membrane trafficking. Traffic 11 (9), 1119\u20131128 (2010).","journal-title":"Traffic"},{"issue":"1","key":"22918_CR30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41467-017-00108-3","volume":"8","author":"C Medina-Gomez","year":"2017","unstructured":"Medina-Gomez, C. et al. Bivariate genome-wide association meta-analysis of pediatric musculoskeletal traits reveals pleiotropic effects at the SREBF1\/TOM1L2 locus. Nat. Commun. 8 (1), 121 (2017).","journal-title":"Nat. Commun."},{"issue":"8","key":"22918_CR31","first-page":"552","volume":"3","author":"A Rezaianzadeh","year":"2012","unstructured":"Rezaianzadeh, A., Namayandeh, S. M. & Sadr, S. M. National cholesterol education program adult treatment panel III versus international diabetic federation definition of metabolic Syndrome, which one is associated with diabetes mellitus and coronary artery disease? Int. J. Prev. Med. 3 (8), 552\u2013558 (2012).","journal-title":"Int. J. Prev. Med."},{"issue":"17","key":"22918_CR32","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy, S. M. et al. Diagnosis and management of the metabolic syndrome: an American heart Association\/National heart, Lung, and blood Institute scientific statement. Circulation 112 (17), 2735\u20132752 (2005).","journal-title":"Circulation"},{"issue":"18","key":"22918_CR33","doi-asserted-by":"publisher","first-page":"6823","DOI":"10.1093\/nar\/gki987","volume":"33","author":"DJ Weisenberger","year":"2005","unstructured":"Weisenberger, D. J. et al. DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight. Nucleic Acids Res. 33 (18), 6823\u20136836 (2005).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"22918_CR34","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1093\/bioinformatics\/btr167","volume":"27","author":"F Krueger","year":"2011","unstructured":"Krueger, F. & Andrews, S. R. Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics 27 (11), 1571\u20131572 (2011).","journal-title":"Bioinformatics"},{"issue":"2","key":"22918_CR35","first-page":"30","volume":"4","author":"Z Zhang","year":"2016","unstructured":"Zhang, Z. Multiple imputation with multivariate imputation by chained equation (MICE) package. Ann. Transl Med. 4 (2), 30 (2016).","journal-title":"Ann. Transl Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22918-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22918-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22918-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:57:50Z","timestamp":1762883870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22918-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22918"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-22918-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"2 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. All participants have given informed consent. Participants were part of a prospective study on cardiovascular disease risk during the first year of CBCT treatment in TC patients. This study was performed in the University Medical Centre Groningen (UMCG) between 2008 and 2012 and approved by the Research Ethics Committee of the UMCG. This study was also approved by Regional Ethical Committee (REC) south east D in Norway, reference 2015\/1332.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"JG received research funding from Roche, Abbvie and Siemens, paid to the Institution. The rest of authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39452"}}